Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09
Carey N et al. – Monotherapy with either entecavir or tenofovir is the current preferred option in treatment–naive patients. Combination therapy is appropriate in those with drug–resistant HBV infection, where drug choice is guided by the viral drug–resistance genotype/phenotype. Although combination therapy has been advocated in other patient groups (e.g., those with decompensated cirrhosis and following liver transplantation), there are, as yet, no data to mandate the use of combination therapy in such patients and any perceived benefit must be weighed against increased cost and risk for toxicity.
Related Articles
Hepatitis B does not increase risk for pancreatic cancer
EurekAlert, 11/02/09
Relevance Score: 70%
Acute Renal Failure Associated with Acute Non-fulminant Hepatitis A: A Case Report and Review of Literature
Renal Failure, 10/30/09
Relevance Score: 69%
De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Liver Transplantation, 10/30/09
Relevance Score: 69%
A Significant Proportion of Patients With Chronic Hepatitis B Who are Candidates for Antiviral Treatment are Untreated: A Region-wide Survey in Italy
Journal of Clinical Gastroenterology, 10/22/09
Relevance Score: 69%
Evaluation of Hepatitis C Virus Core Antigen Assays in Detecting the Recombinant Viral Antigens of Various Genotypes
Journal of Clinical Microbiology, 10/08/09
Relevance Score: 69%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
Antimicrobial Agents and Chemotherapy, 11/20/09
Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin
Antimicrobial Agents and Chemotherapy, 11/20/09
Transcriptomic Profiling of the Saccharomyces cerevisiae Response to Quinine Reveals a Glucose Limitation Response Attributable to Drug-Induced Inhibition of Glucose Uptake
Antimicrobial Agents and Chemotherapy, 11/20/09
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines
Clinical Cancer Research, 11/20/09
Increasing Importance of Multidrug-Resistant Serotype 6A Streptococcus pneumoniae Clones in Acute Otitis Media in Southern Israel
The Pediatric Infectious Disease Journal, 11/20/09
Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome
Retrovirology, 11/19/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter OATP2A1 expressed in human gastroduodenal mucosa
Journal of Pharmacology and Experimental Therapeutics, 11/20/09
Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with Chemotherapy
Infection, 11/19/09
The Helicobacter pylori Mfd protein is important for antibiotic resistance and DNA repair
Diagnostic Microbiology and Infectious Disease, 11/17/09
Sponsor
Article Search
Sponsor


See Latest Articles


